Enteric Coronavirus Infection and Treatment Modeled With an Immunocompetent Human Intestine-On-A-Chip
Pharmacology
[키워드] ACE2 protein
ACE2 receptor
Anti-inflammatory
Anti-viral
approved
cellular
circulating
coronavirus
Coronavirus infection
Coronaviruses
COVID-19
COVID19 patients
Culture
cytokine production
cytokine secretion
deformation
demonstrated
drug
Effect
effective
Endothelium
enteric
Gastrointestinal symptom
Host
Human
human gastrointestinal tract
infect cells
Infection
Inflammation
Inflammatory
Inflammatory response
inhibited
intestinal
intestinal epithelial cell
intestinal epithelium
intestine
intestine chip
mononuclear cell
nafamostat
NL63
Organoid
organs on chip
pathology
Patient
PBMCs
Peripheral blood
Protease inhibitor
recruitment
reduction in
Remdesevir
Remdesivir
SARS-CoV-2
SARS–CoV–2
These data
Vascular endothelium
viral entry
Viral load
Viral protein
[DOI] 10.3389/fphar.2021.718484 PMC 바로가기 [Article Type] Pharmacology
[DOI] 10.3389/fphar.2021.718484 PMC 바로가기 [Article Type] Pharmacology